Cargando…

Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment

BACKGROUND: Clusterin (CLU) /Apolipoprotein J is a protein biosensor of oxidative stress and inflammation, which is upregulated in many pathological processes including atherosclerosis. Previous studies have shown that in aortic tissue, CLU expression increases with atherosclerotic lesion progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanni, Amalia E, Agrogiannis, George, Gkekas, Christos, Perrea, Despina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005404/
https://www.ncbi.nlm.nih.gov/pubmed/24758255
http://dx.doi.org/10.1186/1476-511X-13-70
_version_ 1782314096951033856
author Yanni, Amalia E
Agrogiannis, George
Gkekas, Christos
Perrea, Despina
author_facet Yanni, Amalia E
Agrogiannis, George
Gkekas, Christos
Perrea, Despina
author_sort Yanni, Amalia E
collection PubMed
description BACKGROUND: Clusterin (CLU) /Apolipoprotein J is a protein biosensor of oxidative stress and inflammation, which is upregulated in many pathological processes including atherosclerosis. Previous studies have shown that in aortic tissue, CLU expression increases with atherosclerotic lesion progression and it has been coupled with vascular damage and coronary artery disease. A few studies enter into CLU and carotid atherosclerosis while the apolipoprotein’s expression on human carotid tissue and its association with parameters related to the disease development has not been examined. The present study was designed to reveal the relationships between the degree of CLU immunolocalization on carotid artery and demographic characteristics, blood parameters and pharmacological treatment of patients underwent internal carotid artery endarterectomy. METHODS: CLU expression was detected by immunohistochemistry in 42 carotid endarterectomy specimens. Patients’ serum levels of tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), high sensitive C-reactive protein (hsCRP) and classical parameters related to atherosclerosis such as lipid profile, as well as thrombosis related parameters such as fibrinogen, antithrombin III, protein C and protein S were determined. Demographic characteristics, smoking habits and the use of medications were recorded. Comparisons between groups were performed by students’t-test and analysis of variance. Independent associations with CLU expression on carotid tissue were denoted by linear regression analysis. RESULTS: CLU imuunolocalization was denser in smokers than in non-smokers (p = 0.041) while it was rarefied in specimens of patients on cropidogrel treatment (p = 0.045) compared to the rest not taking this medication. Clopidogrel intake was independent predictor of lower CLU expression on carotid artery (p =0.045). CLU was positively correlated with serum TNF-a concentration (r = 0.33, p = 0.040) that was independent predictor of higher expression of the apolipoprotein (p = 0.001). IL-6, hsCRP and classical parameters related to atherosclerosis and thrombosis were not associated with CLU immunolocalization. CONCLUSION: Our study suggests that CLU expression on carotid artery is affected by TNF-alpha, cigarette smoking confirming its association with oxidative and cellular stress and anti-platelet medication reflecting the protective effects of such pharmacological treatment on vascular wall.
format Online
Article
Text
id pubmed-4005404
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40054042014-05-01 Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment Yanni, Amalia E Agrogiannis, George Gkekas, Christos Perrea, Despina Lipids Health Dis Research BACKGROUND: Clusterin (CLU) /Apolipoprotein J is a protein biosensor of oxidative stress and inflammation, which is upregulated in many pathological processes including atherosclerosis. Previous studies have shown that in aortic tissue, CLU expression increases with atherosclerotic lesion progression and it has been coupled with vascular damage and coronary artery disease. A few studies enter into CLU and carotid atherosclerosis while the apolipoprotein’s expression on human carotid tissue and its association with parameters related to the disease development has not been examined. The present study was designed to reveal the relationships between the degree of CLU immunolocalization on carotid artery and demographic characteristics, blood parameters and pharmacological treatment of patients underwent internal carotid artery endarterectomy. METHODS: CLU expression was detected by immunohistochemistry in 42 carotid endarterectomy specimens. Patients’ serum levels of tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), high sensitive C-reactive protein (hsCRP) and classical parameters related to atherosclerosis such as lipid profile, as well as thrombosis related parameters such as fibrinogen, antithrombin III, protein C and protein S were determined. Demographic characteristics, smoking habits and the use of medications were recorded. Comparisons between groups were performed by students’t-test and analysis of variance. Independent associations with CLU expression on carotid tissue were denoted by linear regression analysis. RESULTS: CLU imuunolocalization was denser in smokers than in non-smokers (p = 0.041) while it was rarefied in specimens of patients on cropidogrel treatment (p = 0.045) compared to the rest not taking this medication. Clopidogrel intake was independent predictor of lower CLU expression on carotid artery (p =0.045). CLU was positively correlated with serum TNF-a concentration (r = 0.33, p = 0.040) that was independent predictor of higher expression of the apolipoprotein (p = 0.001). IL-6, hsCRP and classical parameters related to atherosclerosis and thrombosis were not associated with CLU immunolocalization. CONCLUSION: Our study suggests that CLU expression on carotid artery is affected by TNF-alpha, cigarette smoking confirming its association with oxidative and cellular stress and anti-platelet medication reflecting the protective effects of such pharmacological treatment on vascular wall. BioMed Central 2014-04-23 /pmc/articles/PMC4005404/ /pubmed/24758255 http://dx.doi.org/10.1186/1476-511X-13-70 Text en Copyright © 2014 Yanni et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yanni, Amalia E
Agrogiannis, George
Gkekas, Christos
Perrea, Despina
Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment
title Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment
title_full Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment
title_fullStr Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment
title_full_unstemmed Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment
title_short Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment
title_sort clusterin/apolipoprotein j immunolocalization on carotid artery is affected by tnf-alpha, cigarette smoking and anti-platelet treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005404/
https://www.ncbi.nlm.nih.gov/pubmed/24758255
http://dx.doi.org/10.1186/1476-511X-13-70
work_keys_str_mv AT yanniamaliae clusterinapolipoproteinjimmunolocalizationoncarotidarteryisaffectedbytnfalphacigarettesmokingandantiplatelettreatment
AT agrogiannisgeorge clusterinapolipoproteinjimmunolocalizationoncarotidarteryisaffectedbytnfalphacigarettesmokingandantiplatelettreatment
AT gkekaschristos clusterinapolipoproteinjimmunolocalizationoncarotidarteryisaffectedbytnfalphacigarettesmokingandantiplatelettreatment
AT perreadespina clusterinapolipoproteinjimmunolocalizationoncarotidarteryisaffectedbytnfalphacigarettesmokingandantiplatelettreatment